01/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2024

Jan 28, 2024, 12:51 | Blog
Gemma Peters: Some thoughts and learnings from these past 12 months and how we’re looking to Macmillan’s future
Gemma Peters, Chief Executive Officer of Macmillan Cancer Support, recently shared on LinkedIn: "It’s been…
Jan 28, 2024, 12:51 | Blog
Sean Lybrand: Discussing the progress of the Readiness for Access to Cancer Medicines program in Paraguay
Sean Lybrand, Executive Director at Amgen, shared on LinkedIn: “In Geneva this week, focusing on…
Jan 28, 2024, 12:42 | Blog
Mike Hoerger: In a "bleak milestone," new cancer diagnoses exceed 2 million/year for the 1st time in U.S. history
Mike Hoerger, Director of the top public U.S. COVID forecasting dashboard (PMC), made the following…
Jan 28, 2024, 11:45 | Blog
Rebecca Shatsky: Why on earth would insurance get to decide how I practice medicine!
Rebecca Shatsky shared on X/Twitter: "Just found out an insurance company is trying to deny my…
Jan 28, 2024, 10:45 | Blog
Peter Pisters: Superb efforts toward fostering a personalised and compassionate environment for our patients
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, shared a post…
Jan 28, 2024, 09:08 | Blog
Terry Williams: No doubt she will be a great partner to drive transformative change in our radonc and oncology programs
Terry Williams, Professor and Chair of the Department of Radiation Oncology at the City of…
Jan 28, 2024, 09:01 | Stories
David Fajgenbaum: Even in our darkest hours, there's potential for incredible triumph
David Fajgenbaum, Physician-scientist at the University of Pennsylvania, shared a post on X/Twitter: “When I…
Jan 28, 2024, 08:46 | Blog
Dong-Woo Kang: Honoured to receive the National Cancer Institute K99/R00 pathway to independence grant
Dong-Woo Kang, Instructor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, recently shared…
Jan 28, 2024, 05:57 | Blog
Giacomo Gorini: Phase II results of an anti-melanoma mRNA vaccine by Moderna and Merck
Giacomo Gorini, antibody immunologist from the Ragon Institute of Mass General, MIT, and Harvard, shared…
Jan 28, 2024, 05:50 | Blog
Adam Selipsky: Hurone AI is incorporating Amazon Bedrock in its cancer care platform, making care more accessible for patients in Rwanda, Kenya, and Nigeria
Adam Selipsky, CEO at Amazon Web Services (AWS), shared on LinkedIn: "More than 700 million…
All: 710 Posts: 101 - 110
Special Coverage